In conclusion, biomarkers such as FCN3 and SMOC2 exhibit potential for diagnosis, emphasizing the necessity of continued investigation into their roles as diagnostic tools and therapeutic targets in heart failure management. The gene discussed is SMOC2; the disease is heart failure.